ArticleThe Prostate2025

PRMT5:MEP50 Are Mediators of Treatment-Induced Neuroendocrine Differentiation in Prostate Cancer.

Hye Seung Nam et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.